Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,137,000 | 12,896,000 | 5,798,000 | 10,244,000 | 12,836,000 |
| Marketable Securities | N/A | N/A | 6,744,000 | N/A | N/A |
| Receivables | 4,259,000 | 3,928,000 | 3,697,000 | 3,633,000 | 3,592,000 |
| Inventories | 3,269,000 | 3,147,000 | 2,963,000 | 2,771,000 | 2,771,000 |
| Other current assets | 1,497,000 | 1,909,000 | 1,613,000 | 1,324,000 | 1,445,000 |
| TOTAL | $20,162,000 | $21,880,000 | $20,815,000 | $17,972,000 | $20,644,000 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 6,321,000 | N/A | N/A |
| Investments And Advances | 0 | 0 | 6,483,000 | 0 | 0 |
| Intangibles | 0 | 0 | 4,395,000 | 0 | 0 |
| Other Non-Current Assets | 25,475,000 | 24,782,000 | 7,011,000 | 22,799,000 | 22,202,000 |
| TOTAL | $25,475,000 | $24,782,000 | $24,210,000 | $22,799,000 | $22,202,000 |
| Total Assets | $45,637,000 | $46,662,000 | $45,025,000 | $40,771,000 | $42,846,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,948,000 | 2,981,000 | 2,841,000 | 3,302,000 | 3,435,000 |
| Accounts payable and accrued liabilities | 1,433,000 | 1,288,000 | 1,266,000 | 941,000 | 1,021,000 |
| Other current liabilities | 4,439,000 | 5,272,000 | 4,165,000 | 3,969,000 | 3,616,000 |
| TOTAL | $9,820,000 | $9,541,000 | $8,272,000 | $8,212,000 | $8,072,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,022,000 | 2,898,000 | 2,729,000 | 1,572,000 | 1,586,000 |
| Other Non-Current Liabilities | 6,308,000 | 6,207,000 | 2,870,000 | 5,327,000 | 5,393,000 |
| TOTAL | $9,335,000 | $9,108,000 | $8,418,000 | $6,909,000 | $6,984,000 |
| Total Liabilities | $19,155,000 | $18,649,000 | $16,690,000 | $15,121,000 | $15,056,000 |
| Shareholders' Equity | |||||
| Common Shares | N/A | N/A | 1,025,000 | N/A | N/A |
| Retained earnings | N/A | N/A | 27,371,000 | N/A | N/A |
| Other shareholders' equity | 26,482,000 | 28,013,000 | 66,000 | 25,650,000 | 27,790,000 |
| TOTAL | $26,482,000 | $28,013,000 | $28,335,000 | $25,650,000 | $27,790,000 |
| Total Liabilities And Equity | $45,637,000 | $46,662,000 | $45,025,000 | $40,771,000 | $42,846,000 |